Avalon GloboCare Corp. (NASDAQ:ALBT – Free Report)’s stock is going to reverse split on the morning of Monday, October 28th. The 1-15 reverse split was announced on Thursday, October 24th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, October 25th.
Avalon GloboCare Stock Up 13.7 %
ALBT opened at $0.23 on Friday. Avalon GloboCare has a 52-week low of $0.16 and a 52-week high of $1.44. The company has a market cap of $2.55 million, a P/E ratio of -0.16 and a beta of 0.31. The firm’s 50-day moving average price is $0.24 and its 200-day moving average price is $0.33.
Avalon GloboCare (NASDAQ:ALBT – Get Free Report) last posted its quarterly earnings data on Monday, August 19th. The company reported ($0.19) earnings per share (EPS) for the quarter. The firm had revenue of $0.33 million for the quarter.
About Avalon GloboCare
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.
Featured Articles
- Five stocks we like better than Avalon GloboCare
- What is the Hang Seng index?
- Texas Roadhouse Stock Steering for New Highs This Year
- Most active stocks: Dollar volume vs share volume
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- When to Sell a Stock for Profit or Loss
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Avalon GloboCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon GloboCare and related companies with MarketBeat.com's FREE daily email newsletter.